STAT+: PBMs agree to display TrumpRx drug prices
Bristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The Readout Source: https://www.statnews.com/2026/08/14/biotech-news-pbms-agree-to-display-trumprx-drug-prices/?utm_campaign=rss
STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism
A lab that tussled with regulators over impurities found in widely used medicines has accused U.S. Pharmacopeia of making false and misleading remarks about its methods. Source: https://www.statnews.com/pharmalot/2026/08/14/controversial-lab-sues-usp-for-disparaging-its-testing-methods/?utm_campaign=rss
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer Source: https://www.statnews.com/pharmalot/2026/08/14/lab-tests-lawsuit-bristol-multiple-myeloma-drug-approved/?utm_campaign=rss
Opinion: The Lindsay Clancy case shows the limits of postpartum psychiatry
“Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate,” experts write. Source: https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss
STAT+: Cancer patients face longer wait times to begin treatment, according to new study
“Across every cancer we studied, patients are waiting longer today than they were a decade ago.” Source: https://www.statnews.com/2026/08/12/cancer-patients-face-longer-wait-times-for-treatment/?utm_campaign=rss
STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide Source: https://www.statnews.com/pharmalot/2026/08/12/lilly-black-market-lawsuits-trump-vaccine-plan-pushback/?utm_campaign=rss
STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
The FDA, while promising flexibility in approving Baby KJ-type gene editing, still has set standards difficult for a small startup to meet. Source: https://www.statnews.com/2026/08/04/aurora-therapeutics-ends-program-baby-kj-treatments-beam-therapeutics-jennifer-doudna/?utm_campaign=rss
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
Ebola has killed more than 1,700 people in eastern Congo in what has become the fastest-growing outbreak of the disease. Source: https://www.statnews.com/2026/08/04/ebola-1700-deaths-eastern-congo-fastest-growing-outbreak/?utm_campaign=rss
STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals. Source: https://www.statnews.com/pharmalot/2026/07/31/trump-administration-revises-rebate-pilot-drug-discount-program-hospitals/?utm_campaign=rss
There are already more U.S. measles cases this year than in all of 2025
The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of 2026 still to come. Source: https://www.statnews.com/2026/07/24/measles-cases-surpass-2025-total-national-vaccination-rate-now-below-key-threshold/?utm_campaign=rss
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
“Consumers should not be faced with a trade-off between nutrition and food safety,” writes Susan Mayne, former director of the FDA Center for Food Safety and Applied Nutrition. Source: https://www.statnews.com/2026/07/24/cyclospora-outbreak-contradiction-eat-real-food-less-safety-monitoring/?utm_campaign=rss
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
Robert F. Kennedy Jr. has lauded peptides and said he takes them himself. Source: https://www.statnews.com/2026/07/24/fda-peptide-compounding-panel-backs-epitalon-rejects-emideltide/?utm_campaign=rss
STAT+: Improvements in Alzheimer’s testing could make diagnostics more accessible, informative
Alzheimer's research is moving in new directions, finding ways to make testing much more accessible, and offering more nuanced results. Source: https://www.statnews.com/2026/07/15/aaic-in-30-alzheimers-treaatments-dementia-conference-diagnostics-treatments/?utm_campaign=rss
STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis
A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis. Source: https://www.statnews.com/2026/07/15/epstein-barr-virus-immune-response-multiple-sclerosis-new-study/?utm_campaign=rss
Cassidy grills Trump nominee on past vaccine comments in heated exchange
Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC. Source: https://www.statnews.com/2026/07/15/bill-cassidy-sean-kaufman-confirmation-clash-mrna-hepatitis-b-vaccines/?utm_campaign=rss
STAT+: What does DeGette’s loss mean for pharma?
Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to the industry. Source: https://www.statnews.com/2026/07/02/degette-loses-to-kiros-pharma-presidential-fitness-test-dc-diagnosis/?utm_campaign=rss
STAT+: Medicare takes another swing at 340B cuts to hospitals
Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program. Source: https://www.statnews.com/2026/07/02/medicare-hospital-payment-340b-drugs-cut/?utm_campaign=rss
STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings
The health insurer says CMS didn't calculate its star ratings appropriately. Source: https://www.statnews.com/2026/07/02/elevance-lawsuit-medicare-advantage-star-ratings-clover/?utm_campaign=rss
STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals
Lawmakers step into a dispute between Eli Lilly and hospitals about the 340b drug discount program. Source: https://www.statnews.com/pharmalot/2026/07/02/lawmakers-urge-lilly-to-provide-340b-drug-discounts-to-hospitals/?utm_campaign=rss
STAT+: Pharmalittle: We’re reading about another FDA reversal, pharma’s M&A spree and much more
The latest pharma news from the Pharmalot campus via the Pharmalittle newsletter is here Source: https://www.statnews.com/pharmalot/2026/06/22/another-fda-reversal-pharma-merger-and-acquisition-spree/?utm_campaign=rss